BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.11 | +51.9% |
| 2024 | $-2.31 | +61.5% |
| 2023 | $-6.00 | -809.1% |
| 2022 | $-0.66 | +2.9% |
| 2021 | $-0.68 | +36.4% |
| 2020 | $-1.07 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.11 | +51.9% |
| 2024 | $-2.31 | +61.5% |
| 2023 | $-6.00 | -809.1% |
| 2022 | $-0.66 | +2.9% |
| 2021 | $-0.68 | +36.4% |
| 2020 | $-1.07 | — |